Curis (CRIS)

• Market cap: $19.3M
• 1 day: -1.4%
• 5 days: 4.68%
• 1 month: -15.03%
• 3 months: -55.48%
• 6 months: -60.46%
• Year to date: -49.73%
• 1 year: -75.77%
• 5 years: -99.82%
• 10 years: -99.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 24